Get started

Niftypharma

We may see Sell on Rise in Nifty as Momentum fades downSo now 25420 Support has been breached in NSE:NIFTY . Next would be 25222 as we analysed on weekly Nifty commentary. Today's candle in #NIfty is a Squat Candle which forms when traders book profit on rise. However, Buyers were still stronger than Sellers by 6 million volume. Seems like a Short Build up pattern. Volume rising + Momentum is falling = we will short on a bounce. Option traders must note this. After 25222, 25050 could be the next important support. Resistance for Nifty would be at 25600. We can see a decent short covering if we close above this. NSE:BANKNIFTY looks weaker. NSE:CNXPSUBANK couldn't push it as expected. Support to open new short term position is now marked at 56111. Talking about the Sector specific trades, NSE:CNXPHARMA , #AUTOCOMPONENTS AND NSE:CNXIT tops the list. Remember, this is no time to open Short term positions. We will soon get that good opportunity. So keep some cash handy so that you can the chance when there is opportunity is visible. Currently is the time to do just Intraday and Swing trading. That will be all for the day. Don't forget to use strict SL in this market. Do not use MTF trading. Take care. Have a profitable tomorrow.
NSE:NIFTY
by Trendxinc
TORRENT PHARMACEUTICALS LTD. (TORPHARM) View: Bullish on confirmed breakout. Bias: Positive momentum building. Strategy: BUY: Above ₹3600 (on weekly closing basis with strong volume confirmation). Targets (T): T1: ₹3750 T2: ₹3950+ Stop-Loss (SL): ₹3400 (on weekly closing basis). Reasoning: Strong support at ₹3000-₹3050. Challenging multi-month descending trendline resistance. Positive RSI divergence and increasing volume. Potential for a significant trend reversal if breakout is confirmed.
NSE:TORNTPHARMLong
by rmhetre15
TORNTPHARM Final Bearish move before bulls entry????Yesssss!!!! Chart patterns suggest me the above titled opinion... TORNTPHARM has been travelling in a Ascending Expanding channel pattern IN A BULLISH MODE MAKING SERIES OF HIGHER HIGHS AND HIGHER LOWS... (shown below) Inside the bullish pattern , it is now currently in the downward phase that too inside rectangular descending channel pattern making a SERIES OF LOWER HIGHS AND LOWER LOWS.... It's moving like a written script till now....let's wait and watch whether the director(market) has any twist in the script or not!!! This is just my opinion....not a tip nor advice!!!! Thank you!!!!!!!
NSE:TORNTPHARMShort
by mmjimm
(NSE:SUNPHARMA) Inverted H&S Breakout Eyes New ATH Chart Analysis: Sun Pharma has formed a textbook Inverted Head & Shoulders (H&S) pattern on the daily timeframe, signaling a strong bullish reversal. The pattern completed with a clean breakout above the neckline at ₹1,820 , accompanied by a surge in trading volume (highest in 2 weeks). This validates buyer conviction and sets the stage for a sustained upward move. Key Levels: Neckline: ₹1,820 Resistance Targets: Target 1: ₹1,910 Target 2: ₹1,960 (All-Time High, ATH) Support Zone:1,750 Trade Setup: Entry Zone: ₹1,820–1,835 (post-breakout retest opportunity) Stop Loss: ₹1,750 (below the right shoulder to avoid false breaks) Why This Works? ✅ Pure Price Action Focus: The analysis relies solely on pattern structure, volume, and key levels—no indicators cluttering the chart. ✅ Volume Confirmation: Breakout supported by above average volume, reinforcing bullish momentum. ✅ Pattern Perfection: Classic Inverted H&S structure with well-defined neckline and symmetry. ✅ Breakout Conviction: Price closed decisively above ₹1,820, indicating strong follow-through. For Indicator Users: Traders who incorporate tools like RSI or Moving Averages can cross-verify this setup with their preferred strategies. For instance, the breakout aligns with bullish momentum on higher timeframes. Risk Management: Trail stops to lock profits as price approaches ₹1,910. Partial profit booking at ₹1,910 (T1) recommended. Conclusion: Sun Pharma’s breakout above ₹1,820 opens the door for a rally toward its ATH. Pure price action traders can leverage the clean setup, while others may combine it with their preferred indicators. Focus on the neckline (₹1,820–1,835) for potential entries, and maintain strict risk management. *This analysis is for educational purposes only and does not constitute financial advice, investment recommendation, or an offer to buy/sell securities. Trading involves substantial risk of loss, and past performance is not indicative of future results.
NSE:SUNPHARMA
by Alert_Trader
ALKEM IN BEARS PRESCRIPTION????YES!!!! Chart patterns implies a downward possible move in ALKEM LABS. 1. Every detail given in the chart.....highs and lower highs...lows and lower lows forming a evergreat trading pattern 2. Adding to that, 3 Black crows with good volumes adds probability to the trade. 3. Its been travelling in descending channel pattern...now at the resistance.... Let the Market decide!!!! Let's wait and watch!!!! This is just my opinion....not a tip nor advice!!!!! Thankyou!!!! mmjimm.
NSE:ALKEMShort
by mmjimm
SYNCOMF FOR 3-6 MONTHSFor 3-6 Months Fundamentally, > Revenue Growth over 60% Quarterly > Net Income Growth over 70% Quarterly > EPS over 40% Yearly Technically, > Trading at the point of historically tested demand zone. > Rising relative strength. > Market Profile also suggesting an upmove. > Current levels suggests buyer's entry with volumes. Risk to Reward is 1:2.5 or more Profit Targets: 22-28, Can book some profits at first target and then trail SL further. Stop Loss: Below the current support, 19
NSE:SYNCOMFLong
by madhubansal
LAURUS LAB By KRS ChartsDate: 21st Aug 2024 Time: 9:32 AM Why Laurus Lab? 1. Correction Wave was finished with 5th wave low in Mar 2023, after that it gradually moving up and made upside channeling. 2. Currently price is sustaining above 100 EMA and likely to reversed from that too. 🤞 3. why I'm keen to post L Lab is because along with both above points its likely to close and try to be making Morning Star at bottom in 1W TF. Lauras Lab is at better price at this level with Future Targets of 525 and 605. SL would be flexible Weekly Closing Below 100EMA Once Morning Star Closing will confirm at end of this week this trade will Activated 🎇
NSE:LAURUSLABSLong
by KRSCharts
2
Aurobindo Pharma: Breakout with a Long Opportunity?Aurobindo Pharma is showing signs of a trend reversal on the daily chart. The stock has broken above a descending trendline, supported by strong volumes, signaling a potential bullish move. Key Levels to Watch: Support: ₹1,253 Resistance: ₹1,346 and ₹1,407 Long Opportunity: If the stock sustains above ₹1,300, it offers a good long opportunity with a target of ₹1,407 in the short term. A close above ₹1,407 could open doors to further upside. Traders can consider ₹1,253 as a stop-loss for a risk-managed entry. A decisive move above ₹1,346 will confirm bullish momentum, making this a promising setup for long-term gains.
NSE:AUROPHARMALong
by ayusharya_001
Lupin Ltd: Technical Analysis - December 2024Lupin Ltd (NSE: LUPIN) has displayed an impressive uptrend throughout 2024, supported by a strong ascending trendline (yellow). The stock has experienced healthy corrections along the way, forming a well-defined channel (blue) during its recent consolidation phase. Let’s break it down: Key Observations: Uptrend Continuation: The broader trend remains bullish, with the stock bouncing off the lower boundary of the channel and showing signs of a potential breakout above the resistance. Channel Pattern: A descending channel formation suggests a corrective move within the larger uptrend. The breakout towards the upper end of this channel indicates renewed buying interest. Support & Resistance Levels: Key Support: ₹1,697.50 (red horizontal line), which aligns with a previous demand zone. Immediate Resistance: ₹2,200 - ₹2,250, marking the channel breakout zone. Outlook: A sustained move above ₹2,200 could trigger a new leg of the rally, targeting ₹2,400 and beyond. On the downside, ₹1,900 and ₹1,697.50 will act as crucial supports in case of a pullback. Trading Strategy: Bullish Bias: Buy on dips near ₹2,100-₹2,150 with a stop-loss at ₹1,900. Breakout Play: Enter on a decisive close above ₹2,200 for potential upside. This technical setup provides a promising outlook for Lupin, making it a stock to watch in early 2025.
NSE:LUPINLong
by ayusharya_001
IPCA LABS - Shorts below 1550 you may think of buying a put option or selling futures if IPCA labs closes below 1550 levels and then you can thank me later by boosting, liking and sharing the post. One of the first modern pharma factory of yesteryears was commissioned by Ipca at Mumbai in 1969. The company was originally promoted by a group of medical professionals and businessmen and was incorporated as 'The Indian Pharmaceutical Combine Association Limited. ' in October 1949. Thank you.
NSE:IPCALABShort
by piyushbafna000
Torrent PharmaAll important points are marked. 𝐃𝐢𝐬𝐜𝐥𝐚𝐢𝐦𝐞𝐫: 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐢𝐧 𝐬𝐞𝐜𝐮𝐫𝐢𝐭𝐢𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐚𝐫𝐞 𝐬𝐮𝐛𝐣𝐞𝐜𝐭 𝐭𝐨 𝐦𝐚𝐫𝐤𝐞𝐭 𝐫𝐢𝐬𝐤𝐬, 𝐫𝐞𝐚𝐝 𝐚𝐥𝐥 𝐭𝐡𝐞 𝐫𝐞𝐥𝐚𝐭𝐞𝐝 𝐝𝐨𝐜𝐮𝐦𝐞𝐧𝐭𝐬 𝐜𝐚𝐫𝐞𝐟𝐮𝐥𝐥𝐲 𝐛𝐞𝐟𝐨𝐫𝐞 𝐢𝐧𝐯𝐞𝐬𝐭𝐢𝐧𝐠. 𝐒𝐭𝐨𝐜𝐤𝐬 𝐬𝐮𝐠𝐠𝐞𝐬𝐭𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐠𝐫𝐨𝐮𝐩 𝐚𝐫𝐞 𝐟𝐨𝐫 𝐞𝐝𝐮𝐜𝐚𝐭𝐢𝐨𝐧 𝐩𝐮𝐫𝐩𝐨𝐬𝐞. 𝐖𝐞 𝐝𝐨𝐧𝐭 𝐦𝐚𝐤𝐞 𝐚𝐧𝐲 𝐩𝐫𝐨𝐟𝐢𝐭𝐬 𝐟𝐫𝐨𝐦 𝐭𝐡𝐢𝐬 𝐫𝐞𝐜𝐨𝐦𝐦𝐞𝐧𝐝𝐚𝐭𝐢𝐨𝐧𝐬 𝐞𝐯𝐞𝐫𝐲𝐭𝐡𝐢𝐧𝐠 𝐬𝐡𝐚𝐫𝐞𝐝 𝐡𝐞𝐫𝐞 𝐚𝐫𝐞 𝐜𝐨𝐦𝐩𝐥𝐞𝐭𝐞𝐥𝐲 𝐨𝐟 𝐟𝐫𝐞𝐞 𝐨𝐟 𝐜𝐨𝐬𝐭.
NSE:TORNTPHARMLong
by sreekumars
GRANULES INDIA LTDBuy above 595 All important points are marked. 𝐃𝐢𝐬𝐜𝐥𝐚𝐢𝐦𝐞𝐫: 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐢𝐧 𝐬𝐞𝐜𝐮𝐫𝐢𝐭𝐢𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐚𝐫𝐞 𝐬𝐮𝐛𝐣𝐞𝐜𝐭 𝐭𝐨 𝐦𝐚𝐫𝐤𝐞𝐭 𝐫𝐢𝐬𝐤𝐬, 𝐫𝐞𝐚𝐝 𝐚𝐥𝐥 𝐭𝐡𝐞 𝐫𝐞𝐥𝐚𝐭𝐞𝐝 𝐝𝐨𝐜𝐮𝐦𝐞𝐧𝐭𝐬 𝐜𝐚𝐫𝐞𝐟𝐮𝐥𝐥𝐲 𝐛𝐞𝐟𝐨𝐫𝐞 𝐢𝐧𝐯𝐞𝐬𝐭𝐢𝐧𝐠. 𝐒𝐭𝐨𝐜𝐤𝐬 𝐬𝐮𝐠𝐠𝐞𝐬𝐭𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐠𝐫𝐨𝐮𝐩 𝐚𝐫𝐞 𝐟𝐨𝐫 𝐞𝐝𝐮𝐜𝐚𝐭𝐢𝐨𝐧 𝐩𝐮𝐫𝐩𝐨𝐬𝐞. 𝐖𝐞 𝐝𝐨𝐧𝐭 𝐦𝐚𝐤𝐞 𝐚𝐧𝐲 𝐩𝐫𝐨𝐟𝐢𝐭𝐬 𝐟𝐫𝐨𝐦 𝐭𝐡𝐢𝐬 𝐫𝐞𝐜𝐨𝐦𝐦𝐞𝐧𝐝𝐚𝐭𝐢𝐨𝐧𝐬 𝐞𝐯𝐞𝐫𝐲𝐭𝐡𝐢𝐧𝐠 𝐬𝐡𝐚𝐫𝐞𝐝 𝐡𝐞𝐫𝐞 𝐚𝐫𝐞 𝐜𝐨𝐦𝐩𝐥𝐞𝐭𝐞𝐥𝐲 𝐨𝐟 𝐟𝐫𝐞𝐞 𝐨𝐟 𝐜𝐨𝐬𝐭.
NSE:GRANULESLong
by sreekumars
AJANTA PHARMA LTDBuy Ajanta above: 3351 only. All important points are marked. 𝐃𝐢𝐬𝐜𝐥𝐚𝐢𝐦𝐞𝐫: 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐢𝐧 𝐬𝐞𝐜𝐮𝐫𝐢𝐭𝐢𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐚𝐫𝐞 𝐬𝐮𝐛𝐣𝐞𝐜𝐭 𝐭𝐨 𝐦𝐚𝐫𝐤𝐞𝐭 𝐫𝐢𝐬𝐤𝐬, 𝐫𝐞𝐚𝐝 𝐚𝐥𝐥 𝐭𝐡𝐞 𝐫𝐞𝐥𝐚𝐭𝐞𝐝 𝐝𝐨𝐜𝐮𝐦𝐞𝐧𝐭𝐬 𝐜𝐚𝐫𝐞𝐟𝐮𝐥𝐥𝐲 𝐛𝐞𝐟𝐨𝐫𝐞 𝐢𝐧𝐯𝐞𝐬𝐭𝐢𝐧𝐠. 𝐒𝐭𝐨𝐜𝐤𝐬 𝐬𝐮𝐠𝐠𝐞𝐬𝐭𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐠𝐫𝐨𝐮𝐩 𝐚𝐫𝐞 𝐟𝐨𝐫 𝐞𝐝𝐮𝐜𝐚𝐭𝐢𝐨𝐧 𝐩𝐮𝐫𝐩𝐨𝐬𝐞. 𝐖𝐞 𝐝𝐨𝐧𝐭 𝐦𝐚𝐤𝐞 𝐚𝐧𝐲 𝐩𝐫𝐨𝐟𝐢𝐭𝐬 𝐟𝐫𝐨𝐦 𝐭𝐡𝐢𝐬 𝐫𝐞𝐜𝐨𝐦𝐦𝐞𝐧𝐝𝐚𝐭𝐢𝐨𝐧𝐬 𝐞𝐯𝐞𝐫𝐲𝐭𝐡𝐢𝐧𝐠 𝐬𝐡𝐚𝐫𝐞𝐝 𝐡𝐞𝐫𝐞 𝐚𝐫𝐞 𝐜𝐨𝐦𝐩𝐥𝐞𝐭𝐞𝐥𝐲 𝐨𝐟 𝐟𝐫𝐞𝐞 𝐨𝐟 𝐜𝐨𝐬𝐭.
NSE:AJANTPHARMLong
by sreekumars
Nifty Pharma: Displaying Strength at the Summit(1) The price has been consistently trending upwards over the past year. (2) Following the breakout of the Pole & Flag pattern, the price surged sharply. (3) Subsequently, the price entered an accumulation phase and began consolidating within a Box pattern, which is a positive sign after a strong rally. (4) After 3 months of consolidation, the price finally broke out and started moving upwards. (5) The price is currently at its all-time high and appears poised to continue rising.
NSE:CNXPHARMA
by GoodluckCapital
4